STEALTH CO

MoldCo is the first therapeutic, telemedicine platform focused on mold exposure—an endemic, growing public health crisis. It provides a comprehensive approach to treating mold toxicity, including specialized biomarker testing, clinically-validated treatments, and access to mold-certified clinicians. These solutions are guided by mold-specialized providers and are available entirely online. MoldCo leverages evidence-based methods to restore metabolic health, clear harmful microbes, and reduce inflammation. The company is rolling out its direct-to-consumer healthcare service nationally and aims to address the often-overlooked health crisis caused by mold exposure.